Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M
AstraZeneca (United States) · Dana-Farber Cancer Institute · +5 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,534
total citations
- FWCI
- 65.47
- Percentile
- 100%
- References
- 16
Citations per year
Authors
16Topics & keywords
Topics
Keywords
- T790M
- Mutation
- Medicine
- Cancer research
- Lung cancer
- Osimertinib
- Epidermal growth factor receptor
- Resistance mutation
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.